Rare diseases
Investigational molecules
Locations
75 Avenue Parmentier, 75544 Paris, France
Clinical research in AL amyloidosis is focused on improving hematologic response in patients who have not achieved an adequate response with previous treatment, with attention to deep response categories such as very good partial response, complete response, and low free light chain burden.
The therapeutic interest extends to patients with persistent disease after prior therapy, with an emphasis on response depth and disease control in a plasma cell disorder affecting amyloid-related organ involvement.
Intergroupe Francophone Du Myelome runs clinical trials in conditions such as Plasma cell myeloma, Amyloidosis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumFranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
